AgeneBio
Carmel
About AgeneBio
AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company is headquartered in Indianapolis but conducts research and development work on a global basis utilizing partner relationships.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.4M
- Last round: Grant (Sep 2019)
- Website: agenebio.com
- Phone: (410) 685-3000
Industries & Categories
Biotechnology, Health Care, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/agenebio-28569 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.